BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 28126258)

  • 1. Clinical impact of admission hyperglycemia on in-hospital mortality in acute myocardial infarction patients.
    Kim EJ; Jeong MH; Kim JH; Ahn TH; Seung KB; Oh DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Kim KB; Kim YJ; Cha KS; Oh SK; Chae JK;
    Int J Cardiol; 2017 Jun; 236():9-15. PubMed ID: 28126258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
    Yang JH; Song PS; Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim YJ; Gwon HC
    Crit Care; 2013 Oct; 17(5):R218. PubMed ID: 24090250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High admission glucose levels predict worse short-term clinical outcome in non-diabetic patients with acute myocardial infraction: a retrospective observational study.
    Ding XS; Wu SS; Chen H; Zhao XQ; Li HW
    BMC Cardiovasc Disord; 2019 Jul; 19(1):163. PubMed ID: 31272376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.
    Dziewierz A; Giszterowicz D; Siudak Z; Rakowski T; Dubiel JS; Dudek D
    Clin Res Cardiol; 2010 Nov; 99(11):715-21. PubMed ID: 20458486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of diabetes mellitus as a risk factor of acute myocardial infarction].
    Peng XR; Zhao YF; Zou DJ; Gu P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.
    Orban M; Mayer K; Morath T; Bernlochner I; Hadamitzky M; Braun S; Schulz S; Hoppmann P; Hausleiter J; Tiroch K; Mehilli J; Schunkert H; Massberg S; Laugwitz KL; Sibbing D; Kastrati A
    Thromb Haemost; 2014 Dec; 112(6):1190-7. PubMed ID: 25183544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
    Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
    Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
    Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends and in-hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST-segment elevation myocardial infarction.
    Kim JY; Jeong MH; Choi YW; Ahn YK; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae IH; Cho MC; Yoon JH; Seung KB;
    Korean J Intern Med; 2015 Nov; 30(6):821-8. PubMed ID: 26552457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Admission hyperglycemia and mortality of ST segment elevation myocardial infarction].
    Greig D; Corbalán R; Castro P; Campos P; Lamich R; Yovaniniz P; Nazzal C
    Rev Med Chil; 2010 Sep; 138(9):1109-16. PubMed ID: 21249278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study.
    Zhao S; Murugiah K; Li N; Li X; Xu ZH; Li J; Cheng C; Mao H; Downing NS; Krumholz HM; Jiang LX
    Chin Med J (Engl); 2017 Apr; 130(7):767-775. PubMed ID: 28345539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.
    Bae EH; Lim SY; Jeong MH; Park HW; Lim JH; Hong YJ; Kim W; Kim JH; Cho JG; Ahn YK; Park JC; Suh SP; Ahn BH; Kim SH; Kang JC
    Korean J Intern Med; 2005 Mar; 20(1):8-14. PubMed ID: 15906947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction.
    Kim U; Park JS; Kang SW; Kim YM; Park WJ; Lee SH; Hong GR; Shin DG; Kim YJ; Jeong MH; Chae SC; Hur SH; Song IW; Hong TJ; Chae IH; Cho MC; Jang Y; Yoon J; Seung KB; Park SJ;
    Am J Cardiol; 2012 Jul; 110(1):36-9. PubMed ID: 22481010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA.
    Paolisso P; Foà A; Bergamaschi L; Angeli F; Fabrizio M; Donati F; Toniolo S; Chiti C; Rinaldi A; Stefanizzi A; Armillotta M; Sansonetti A; Magnani I; Iannopollo G; Rucci P; Casella G; Galiè N; Pizzi C
    Cardiovasc Diabetol; 2021 Sep; 20(1):192. PubMed ID: 34560876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission hyperglycemia in patients with acute coronary syndrome complicated by cardiogenic shock.
    Jaśkiewicz F; Supeł K; Koniarek W; Zielińska M
    Cardiol J; 2015; 22(3):290-5. PubMed ID: 25428733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.